HCV-IN-45 (Compound EI-1) is a hepatitis C virus (HCV) inhibitor that suppresses HCV pseudoparticles (HCVpp) of genotypes 1a and 1b with EC50 values of 0.134 and 0.027 μM, respectively; it also inhibits cell culture-adapted HCV (HCVcc) of chimeric genotypes 1a/2a and 1b/2a with EC50 values of 0.024 and 0.012 μM, respectively; the compound inhibits viral entry into hepatocytes and blocks cell-to-cell spread of the virus.